Results 61 to 70 of about 3,947 (209)

Tumefactive multiple sclerosis

open access: yesRomanian Neurosurgery, 2021
Tumefactive multiple sclerosis is a rare variant of multiple sclerosis, characterized by the presence of brain lesions that may be solitary or multiple. Considering that these lesions have a pseudotumoral appearance, it is a challenge to differentiate them from central nervous system neoplasms through neuroimaging.
Michael Gregorio Ortega-Sierra   +11 more
openaire   +1 more source

The Associations Between Chronic Active Lesions and White Matter Disease: A 7 Tesla Imaging Study

open access: yesAnnals of Clinical and Translational Neurology, Volume 12, Issue 12, Page 2535-2545, December 2025.
ABSTRACT Background The relationship between paramagnetic rim lesions (PRLs) and surrounding normally appearing white matter (NAWM) disease, potentially contributory to the associations seen between PRLs and clinical impairment, is underexplored. Objectives To assess whether PRLs correlate with a greater degree of NAWM injury in early MS.
Ellie McCluey   +17 more
wiley   +1 more source

Serial magnetic resonance imaging changes of pseudotumor lesions in retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations: a case report

open access: yesBMC Neurology, 2021
Background Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations (RVCL-S) is an adult-onset rare monogenic microvasculopathy.
Yuying Yan   +5 more
doaj   +1 more source

IgG4-Related Disease Affecting Testicle and Myelodysplastic Syndrome: Just a Coincidence?

open access: yesEuropean Journal of Case Reports in Internal Medicine, 2021
Immunoglobulin G4-related disease (IgG4-RD) is progressive immune-mediated fibrotic condition characterised by a tendency to form tumefactive lesions in different organs and by elevated IgG4 serum concentrations.
Carla Alvarez Gonzalez   +4 more
doaj   +1 more source

Morel-Lavallee Syndrome: A Rare Tumefactive Lesion

open access: yesEuropean Journal of Case Reports in Internal Medicine, 2020
First described by the French surgeon Maurice Morel-Lavallee in 1853, Morel-Lavallee syndrome (MLS) is a serolymphatic effusion resulting from tangential injury to richly vascularized tissues.
Mohamed Labied   +5 more
doaj   +1 more source

Cerebral tumefactive demyelinating lesions

open access: yesOncology Letters, 2015
Tumefactive demyelinating lesions (TDLs), are a rare demyelinating pathological disease in the central neurological system, which have been proven to be a diagnostic dilemma to neurosurgeons. The clinical presentation and radiographic appearance of these lesions often results in their misdiagnosis as intracranial tumors, such as gliomas, which leads to
Wei, Qi   +4 more
openaire   +3 more sources

Tumefactive demyelinating lesion mimicking glioma: A clino-radiopathological conundrum a rare case report and review of literature

open access: yesIndian Journal of Pathology and Oncology
A rare side effects of idiopathic inflammatory demyelinating disorders of the central nervous system (CNS) include tumefactive demyelinating lesions.
Shivangi Prakash Gandhi   +5 more
semanticscholar   +1 more source

Neuromyelitis Optica Mimicking Multiple Sclerosis: A Case Report and a Comprehensive Review of the Literature

open access: yesClinical Case Reports, Volume 13, Issue 10, October 2025.
Post‐gadolinium enhancement of the spinal cord seen in NMO. ABSTRACT Neuromyelitis optica spectrum disorder (NMOSD) may mimic other neurological conditions, including multiple sclerosis (MS). We report a 25‐year‐old woman with hypothyroidism and depression who presented with progressive quadriparesis.
Sunil Thatal   +6 more
wiley   +1 more source

Tumefactive demyelinating lesions: a retrospective cohort study in Thailand

open access: yesScientific Reports
Tumefactive demyelinating lesions (TDL), characterized by large (≥ 2 cm) demyelinating lesions mimicking tumors, are a rare manifestation of the central nervous system inflammatory demyelinating diseases (CNS-IDD).
Tatchaporn Ongphichetmetha   +7 more
semanticscholar   +1 more source

Durable Response to Pazopanib (Tyrosine Kinase Inhibitor) in a Patient With EWSR1::CREM Gene Fusion Positive Intra‐Abdominal Unclassified Epithelioid Sarcoma

open access: yesGenes, Chromosomes and Cancer, Volume 64, Issue 10, October 2025.
ABSTRACT EWSR1::CREM fusion positive intrabdominal sarcomas defines a rare emerging group of aggressive mesenchymal neoplasms with a predilection for the celomic cavity and often manifesting perplexing immunophenotypic profile. There is no specific standard of care therapeutic option though anecdotal reports response to pazopanib have been reported. We
Saba Shafi   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy